Search by Drug Name or NDC
NDC 00006-4047-41 RotaTeq 2200000; 2800000; 2200000; 2000000; 2300000 [iU]/2mL; [iU]/2mL; [iU]/2mL; [iU]/2mL; [iU]/2mL Details
RotaTeq 2200000; 2800000; 2200000; 2000000; 2300000 [iU]/2mL; [iU]/2mL; [iU]/2mL; [iU]/2mL; [iU]/2mL
RotaTeq is a ORAL SOLUTION in the VACCINE category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is HUMAN ROTAVIRUS A TYPE G1P7(5) STRAIN WI79 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G2P7(5) STRAIN SC2 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G3P7(5) STRAIN WI78 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G4P7(5) STRAIN BRB LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G6P1A(.
MedlinePlus Drug Summary
Why get vaccinated? Rotavirus vaccine can prevent rotavirus disease. Rotavirus commonly causes severe, watery diarrhea, mostly in babies and young children. Vomiting and fever are also common in babies with rotavirus. Children may become dehydrated and need to be hospitalized and can even die.
Related Packages: 00006-4047-41Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Rotavirus Vaccine
Product Information
| NDC | 00006-4047 |
|---|---|
| Product ID | 0006-4047_41789cf7-08b5-43cc-b5ee-5e69ead21e01 |
| Associated GPIs | 17100075102020 |
| GCN Sequence Number | 060364 |
| GCN Sequence Number Description | rotavirus vaccine,live oral pv SOLUTION 2 ML ORAL |
| HIC3 | W7H |
| HIC3 Description | ENTERIC VIRUS VACCINES |
| GCN | 26500 |
| HICL Sequence Number | 033460 |
| HICL Sequence Number Description | ROTAVIRUS VACCINE, LIVE ORAL PENTAVALENT |
| Brand/Generic | Brand |
| Proprietary Name | RotaTeq |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Rotavirus Vaccine, Live, Oral, Pentavalent |
| Product Type | VACCINE |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 2200000; 2800000; 2200000; 2000000; 2300000 |
| Active Ingredient Units | [iU]/2mL; [iU]/2mL; [iU]/2mL; [iU]/2mL; [iU]/2mL |
| Substance Name | HUMAN ROTAVIRUS A TYPE G1P7(5) STRAIN WI79 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G2P7(5) STRAIN SC2 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G3P7(5) STRAIN WI78 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G4P7(5) STRAIN BRB LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G6P1A( |
| Labeler Name | Merck Sharp & Dohme LLC |
| Pharmaceutical Class | Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Rotavirus Vaccine [EPC], Live Rotavirus Vaccine [EPC], Live Rotavirus Vaccine [EPC], |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125122 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00006-4047-41 (00006404741)
| NDC Package Code | 0006-4047-41 |
|---|---|
| Billing NDC | 00006404741 |
| Package | 10 POUCH in 1 CARTON (0006-4047-41) / 1 TUBE in 1 POUCH (0006-4047-02) / 2 mL in 1 TUBE (0006-4047-01) |
| Marketing Start Date | 2006-02-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |